IVAX Corporation
David Malina, 305-575-6043

IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced that the U.S.
District Court in Washington D.C. has extended its temporary
restraining order against the United States Food and Drug
Administration ("FDA") in the Metformin ER case for three more days,
ending at the close of business on Friday, November 21, 2003.

IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.

Copies of this and other news releases may be obtained free of charge
from IVAX' Web site at http://www.ivax.com.